A Comprehensive Guide to Ductal Carcinoma in Situ (DCIS) for Patients

A diagnosis of ductal carcinoma in situ, or DCIS, often comes as a surprise during a routine mammogram. While the news is understandably taxing, it is important to remember that DCIS is a noninvasive, highly treatable stage of breast cancer.

This guide provides a clear roadmap of your diagnosis, treatment options, and recovery process to empower you during discussions with your healthcare team and oncology specialists.

Understanding ductal carcinoma in situ (DCIS)

Ductal carcinoma in situ (DCIS) is a noninvasive condition where abnormal cells are found inside a milk duct in the breast. The term "in situ" means "in its original place." Because the cells have not spread through the walls of the ducts into the surrounding breast tissue, DCIS is often referred to as stage 0 breast cancer.

While DCIS is not life-threatening in its current state, it is considered a precursor to invasive cancer. If left untreated, these cells could potentially break out of the duct and invade nearby tissue. For this reason, nearly all patients undergo treatment to prevent future complications.

The diagnostic process

Most cases of DCIS are asymptomatic and are detected during routine screening mammograms, appearing as tiny clusters of calcium deposits called microcalcifications.

• Imaging: If a screening mammogram shows suspicious areas, a diagnostic mammogram or an ultrasound is performed to get a clearer view.
• Biopsy: A definitive diagnosis requires a biopsy. A needle is used to remove small samples of the suspicious tissue for examination by a pathologist.
• Pathology Report: The report will specify the grade of the DCIS (low, intermediate or high), which describes how much the cells differ from normal cells and how fast they are likely to grow.

Primary treatment options

Treatment is highly personalized based on the size of the area, the grade of the cells and your personal health history.

• Breast-Conserving Surgery (Lumpectomy): The surgeon removes the area of DCIS along with a small margin of healthy tissue, preserving the rest of the breast.
• Mastectomy: In cases where DCIS is widespread or found in multiple areas, the entire breast may be removed.
• Radiation Therapy: Often recommended after a lumpectomy to destroy any remaining abnormal cells and reduce the risk of recurrence.
• Hormone Therapy: If the DCIS is "estrogen receptor-positive," medications like Tamoxifen may be prescribed for five years to lower the risk of future breast cancer.

Potential side effects

Understanding side effects helps you manage your recovery and maintain a high quality of life.

• Surgical Effects: Expect temporary soreness, bruising or swelling. A lumpectomy may cause slight changes in breast shape, while a mastectomy involves a longer recovery and may include numbness.
• Radiation Effects: Common side effects include skin irritation (similar to a sunburn) and fatigue. These typically resolve a few weeks after treatment ends.
• Hormonal Therapy Effects: Depending on the medication, side effects can include hot flashes, joint pain or mood swings.

Moving forward

A diagnosis of DCIS can feel overwhelming, but the prognosis is excellent, with a nearly 100% long-term survival rate. This stage of your journey is about proactive risk management. Your medical team — including your surgeon, radiation oncologist and medical oncologist — will work with you to choose the path that balances effective treatment with your personal preferences.

Patient Tip: Bring a notebook to your appointments. Ask your oncologist: "Given the grade and size of my DCIS, what is the statistical benefit of adding radiation to my surgery?"

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.